Aardvark Therapeutics, Inc.
AARDBiotechnology
$1.44−4.64%As of Oct 29vs prior close
- Market cap
- $31.5M
- P/E (TTM)
- –
- From 52W high
- −90.90%
- EPS (YE25)
- -$2.93
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
25
Steady ProfileBottom 10% of the scored universe
Growth—
Quality38
Value32
Momentum28
Resilience34
Connections
Who owns it
1fund